ANTIMALARIALS (ACTs)

Description: ArtemaCure Plus is a leading ACT for the treatment of uncomplicated malaria caused by Plasmodium falciparum. Uses: Effective in treating uncomplicated malaria, particularly in regions with high resistance to older antimalarial drugs. Forms Available: Tablets Key Benefits: High Efficacy: Proven to have a high cure rate, with a parasitologic cure rate of approximately 98% when adherence is maintained. Rapid Action: Artemether quickly reduces the parasite load, while lumefantrine clears the remaining parasites. Safety Profile: Generally well tolerated with minimal side effects, making it suitable for both adults and children.

Description: Artesunate-Amodiaquine is known for its rapid fever clearance and high cure rates, making it an effective choice for treating uncomplicated malaria. Uses: Primarily used for treating uncomplicated malaria in regions with confirmed efficacy of AS-AQ. Forms Available: Tablets Key Benefits: Rapid Fever Clearance: Provides faster fever clearance compared to other ACTs, improving patient comfort and recovery. High Cure Rates: Demonstrates high efficacy with a parasitologic cure rate of 98.3% on Day 28. Suitability for Children: Effective and safe for use in young children, who are particularly vulnerable to malaria.

Description: DHA-PPQ offers a longer half-life, reducing the frequency of dosing and improving patient compliance. Uses: Used for treating uncomplicated malaria, particularly in areas with high transmission rates. Forms Available: Tablets Key Benefits: Longer Half-Life: The extended half-life of piperaquine helps in reducing the dosing frequency, which enhances patient adherence. High Efficacy: Shows an efficacy rate of 99.6% at Day 28 and Day 42, making it one of the most effective ACTs available. Safety: Well tolerated with a low incidence of adverse drug reactions, making it a safe option for widespread use.